- Home
- IVT vs VERA Comparison
IVT vs VERA Comparison
Compare IVT & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | VERA |
|---|---|---|
| Founded | 2005 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IVT | VERA |
|---|---|---|
| Price | $34.82 | $31.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $32.50 | ★ $81.30 |
| AVG Volume (30 Days) | 658.8K | ★ 1.1M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 647.37 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $299,169,000.00 | N/A |
| Revenue This Year | $8.42 | N/A |
| Revenue Next Year | $5.25 | $472.48 |
| P/E Ratio | $495.43 | ★ N/A |
| Revenue Growth | ★ 9.20 | N/A |
| 52 Week Low | $26.52 | $19.07 |
| 52 Week High | $34.91 | $56.05 |
Technical Indicators
Market Signals| Indicator | IVT | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 72.31 | 38.01 |
| Support Level | $30.42 | $30.59 |
| Resistance Level | N/A | $31.92 |
| Average True Range (ATR) | 0.71 | 2.16 |
| MACD | 0.21 | -0.11 |
| Stochastic Oscillator | 83.54 | 15.82 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.